SYMPLICITY HTN-3 results to be announced: A mystery or a story foretold?

Journal of Biomedical Research

Volumn 28, Issue 2, 2014, Pages 73-74

  Staessena, Jan A ^a   Jina, Yu ^b   Persub, Alexandre ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; HUMAN; KIDNEY DENERVATION; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84902506843     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.28.20140026     Document Type: Note

References (10)

1. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275-81.
2. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9.
3. Santiapillai GR, Ferro A. Renal denervation as an option for the management of hypertension. J Biomed Res 2014;28:18-24.
4. Kandzari DE, Bhatt DL, Sobotka PA, O'Neill WW, Esler M, Flack JM, et al. Catheter-based renal denervation for resistant hypertension: rational and design of the SYMPLICITY HTN-3 trial. Clin Cardiol 2012;35:528-35.
5. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R, et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized control ledtrial. JAMA 1997;278:1065-72.
6. Kaltenbach B, Id D, Franke JC, Sievert H, Hennersdorf M, Maier J, et al. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol 2012;60:2694-5.
7. Persu A, Renkin J, Thijs L, Staessen JA. Renal denervation - Ultima ratio or standard in treatment-resistant hypertension. Hypertension 2012;60:596-606.
8. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension. Durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911-7.
9. Krum H, Schlaich MP, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Percutaneous renal denervation in patients with treatment-resitant hypertension :final 3-year report of the SYMPLICITY HTN-1 study. Lancet 2014;383:622-9.
10. Persu A, Jin Y, Azizi M, Baelen M, Vö lz S, Elvan A, et al:Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens 2014;28:150-6.